COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients [Phase 3]
Phase 3 trial update evaluating high-dose methylprednisolone for COVID-19 pneumonia completed.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia [Phase 3]
Phase 3 trial assessing intravenous almitrine to reduce mechanical ventilation needs in hypoxemic respiratory failure from Covid-19 pneumoni…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Nebulised Heparin in Patients With COVID-19 Pneumonia [Phase 2, Phase 3]
Clinical trial update for nebulised heparin in COVID-19 pneumonia spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Study of Efficacy and Safety of MAS825 in Patients With COVID-19 [Phase 2]
Phase 2 clinical trial of MAS825 for COVID-19 pneumonia with impaired respiratory function has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia [Phase 3]
Phase 3 trial update for leronlimab in moderately ill COVID-19 pneumonia patients; study status is suspended.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation [Phase 3]
Phase 3 trial of leronlimab in COVID-19 pneumonia patients requiring mechanical ventilation or ECMO is suspended.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Efficacy of PJS-539 for Adult Patients With COVID-19. [Phase 2]
Phase 2 trial assessing the efficacy of PJS-539 in adults with COVID-19 and COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia [Phase 2]
Phase 2 trial completed evaluating safety and effect of STC3141 continuous infusion in severe COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intravenous allogeneic adipose-derived mesenchymal stem cells for safety and efficacy in severe COVID-19 pneumo…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury [Phase 2]
Phase 2 clinical trial evaluating CERC-002 for adults with COVID-19 pneumonia and acute lung injury has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: An Open-label, Randomized, Parallel-arm Study Investigating the Efficacy and Safety of Intravenous Administration of Pamrevlumab Versus Standard of Care in Patients With COVID-19 [Phase 2, Phase 3]
Open-label, randomized study comparing intravenous pamrevlumab to standard of care in COVID-19 patients; study phases 2 and 3 have completed…
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease [Phase 1, Phase 2]
A safety-focused clinical trial update on nebulized BromAc® therapy for COVID-19-related respiratory conditions across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia [Phase 3]
Phase 3 trial evaluating remdesivir plus tocilizumab versus remdesivir plus placebo in hospitalized patients with severe COVID-19 pneumonia;…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients [Phase 2]
Phase 2 trial investigating the efficacy and safety of NuSepin® in COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Asunercept in Patients With Severe COVID-19 [Phase 2]
Phase 2 trial update for asunercept in patients with COVID-19–related pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 [Phase 3]
A Phase 3 clinical trial evaluating nebulized fentanyl for respiratory symptoms in COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating MSTT1041A (Astegolimab) or UTTR1147A in patients with severe COVID-19 pneumonia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores [NA]
A completed clinical trial dataset for an oral COVID-19 vaccine using Bacillus subtilis spores has posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial update evaluating hzVSF-v13 for efficacy and safety in patients with COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating DV890 for efficacy and safety in patients with COVID-19 pneumonia has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial evaluating immunogenicity, safety and antibody persistence of a Wuhan-produced COVID-19 booster in patients with hypertension …
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial update evaluating immunogenicity, safety, and antibody persistence of a Beijing-produced COVID-19 booster vaccine in patients …
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19 [Phase 4]
Phase 4 clinical trial evaluating montelukast therapy effects on clinical course, pulmonary function, and mortality in COVID-19 pneumonia pa…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT [Phase 3]
Phase 3 randomized trial evaluating atorvastatin for reducing 28-day mortality in COVID-19; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a COVID-19 vaccine produced in Wuhan in patients with hypertension and/or diabetes (CO…